CacheBy
Thermo Fisher Scientific Human SIPA1L1 Synthetic Peptide
원본

Thermo Fisher Scientific Human SIPA1L1 Synthetic Peptide

상품 한눈에 보기

인간 SIPA1L1 단백질의 N-말단 16개 아미노산 서열 기반 합성 펩타이드. 항체 PA5-20847의 블로킹 펩타이드로 사용 가능. 순도 높은 액상 형태로 제공되며 PBS 버퍼에 0.1% BSA와 0.02% sodium azide 포함. 연구용으로만 사용.

카탈로그번호
PEP0961
카테고리
Protein
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오전 12:59
Thermo Fisher Scientific PEP0961 Human SIPA1L1 Synthetic Peptide 50 ug pk판매 단위 pk ·
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human SIPA1L1 Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage Buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage Conditions -20°C

Product Specific Information

This peptide corresponds to 16 amino acids near the amino terminus of human SIPA1L1.
PEP-0961 can be used as a blocking peptide with polyclonal antibody PA5-20847.

Target Information

Signal-induced proliferation associated-like protein 1 (SIPA1L1) is a member of the SIPA1 family of RapGAPs. SIPA1L1 was initially identified as a binding partner and degradation target of the E6 oncoprotein of high-risk papillomaviruses.
Recently, it was discovered that Casein kinase I epsilon (CKIe), a Wnt-regulated kinase that regulates Wnt/β-catenin signaling, also can bind to the carboxy-terminus of SIPA1L1. CKIe phosphorylates SIPA1L1, thereby reducing its stability and alleviating its inhibition of Rap1, a protein required for Wnt8/CKIe-mediated gastrulation during embryogenesis.
This suggests SIPA1L1 plays important roles in embryo development as well as in control of cell proliferation.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.